Clinical Trial Update: Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating cervicothoracic sympathetic block for Post-COVID-19 condition with autonomic dysfunction; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Dysfunction
• Post-covid-19 Condition

Snippet

Sponsor: University Health Network, Toronto | Conditions: Autonomic Dysfunction | Phase 4 | Status: NOT_YET_RECRUITING